High <i>Skp2</i> Expression Characterizes High-Risk Neuroblastomas Independent of <i>MYCN</i> Status
Frank Westermann(German Cancer Research Center), Manfred Schwab(German Cancer Research Center), Axel Benner(Memorial Sloan Kettering Cancer Center), Karen Ernestus(University of Würzburg), Jun S. Wei(Center for Cancer Research), Benedikt Brors(German Cancer Research Center), Matthias Fischer(University of Cologne), Ruprecht Wiedemeyer(Broad Institute), Rainer König(Jena University Hospital), Volker Ehemann(Heidelberg University), Ivo Leuschner(Christian-Albrechts-Universität zu Kiel), W. Lutz(Philipps University of Marburg), Kai-Oliver Henrich(German Cancer Research Center), Javed Khan(Kent State University)
Cited by 49
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Omic data from evolved E. coli are consistent with computed optimal growth from genome‐scale models
|Molecular Systems Biology|2010|826
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
|Nature Genetics|2020|790